25th Annual PepTalk 2026: The Protein Science and Production Week
ÀÏÁ¤ : 2026³â 1¿ù 19-22ÀÏ
°³ÃÖ: Hilton San Diego Bayfront, San Diego, CA, USA
Choose your language
Traditional Chinese
Simplified Chinese
Japanese
English_

¹ÙÀÌ¿ÀÀǾàǰ ¹ß°ß°ú °³¹ß Áß°³

25ÁÖ³â ÃàÇÏ! PepTalk Çõ½Å

PepTalk 2026Àº ¹ÙÀÌ¿ÀÀǾàǰ ¹ß°ß°ú °³¹ß¿¡¼­ÀÇ ºê·¹ÀÌÅ©½º·ç¸¦ °¡¼Ó½ÃÄѿ 25Áֳ⠱â³ä À̺¥Æ®ÀÔ´Ï´Ù. °úÇÐÀÚ, ¼±±¸ÀÚ, ¾÷°è ¸®´õ°¡ ¸ðÀ̴ Ȱ±âÂù Ä¿¹Â´ÏƼ¿¡ Âü°¡Çϼ¼¿ä. PepTalk´Â ´Ü¹éÁú °úÇп¡¼­ °¡Àå ¿µÇâ·Â ÀÖ´Â À̺¥Æ® Áß Çϳª·Î ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù. Âü½ÅÇÑ ¾ÆÀ̵ð¾î°¡ ¹ßÈ­µÇ°í, Çù¾÷ÀÌ È°¹ßÇØÁö¸ç, Â÷¼¼´ë ¼Ö·ç¼ÇÀÌ Çü¼ºµË´Ï´Ù.

¿ÃÇØ´Â ½ÉÆ÷Áö¾ö ¹× ÄÁÆÛ·±½º Æ®·¢ÀÌ È®´ëµÇ¾î ´Ü¹éÁú ¹ßÇö, »ý»ê Ç÷§Æû, Higher ThroughputÀÇ ·¦ ÀÚµ¿È­, ½Å±Ô ¸ð´Þ¸®Æ¼ÀÇ ºÐ¼® Ư¼º Æò°¡¿Í ÇÁ¸®Æ÷¹Ä·¹ÀÌ¼Ç Àü·«, Ç×ü ¹ß°ß°ú °³¹ß, ±×¸®°í ½Å±âȹÀÎ ÆéƼµå ÀǾà°ú ¹Ì´Ï ´Ü¹éÁú ¹ßÇö°ú °³¹ß¿¡ ´ëÇØ¼­µµ ´Ù·ì´Ï´Ù.

Àü¹®°¡ÀÇ °­¿¬À¸·ÎºÎÅÍ ÀλçÀÌÆ®¸¦ ¾ò°í, Àü¿ë Ä¿¹Â´ÏƼ¿¡ Âü¿©Çϰí, ¿¬±¸¸¦ ÁøÀü½Ãų ¼ö ÀÖ´Â Åø ¹× Àü·«À» °¡Áö°í µ¹¾Æ°¡¼¼¿ä.

4Àϰ£ÀÇ ÁýÁßÀû ÇнÀ, Àü¹®°¡ ÁÖµµ ¼¼¼Ç, Æ÷½ºÅÍ ¹ßÇ¥, ±âÁ¶ °­¿¬, ¶ó¿îµåÅ×À̺í, ÆÐ³Î µð½ºÄ¿¼Ç, Àü½Ãȸ, ±×¸®°í ³×Æ®¿öÅ· ±âȸ¸¦ üÇèÇØ º¸¼¼¿ä.

200 Presentations
200 Presentations
100 Posters
1000 Participants
75 Exhibitors

2025 PLENARY FIRESIDE CHAT


Navigating the Professional Landscape:

Strategic Pathways to Biotech Success

Deborah Moore-Lai

PANEL MODERATOR:
Deborah Moore-Lai, PhD, Vice President, Protein Sciences, ProFound Therapeutics

Emma Altman

PANELISTS:
Emma Altman, Sr. Research Associate, Protein Sciences, Kite, A Gilead Company

Henry C. Chiou

Henry C. Chiou, PhD, Sr. Director General Manager, Biosciences, Thermo Fisher Scientific (Retired)

Frances Maureen Rocamora

Frances Maureen Rocamora, PhD, Assistant Project Scientist, Pediatrics, University of California, San Diego

QC Yong

QC Yong, PhD, Antibody CMC, Associate Director, Capstan Therapeutics


ADDITIONAL 2025 KEYNOTE SPEAKERS INCLUDED:

Matthew DeLisa, PhD

Matthew DeLisa, PhD
Director, Cornell Institute of Biotechnology, Cornell University

Mary Jessel, PhD

Mary Jessel, PhD
Senior Vice President, Global Medical Affairs, Telix Pharmaceuticals

Hitoshi Katada, PhD

Hitoshi Katada, PhD
Head of Biologics Engineering, Research Division, Chugai Pharmaceutical Co. Ltd.

James D. Love, PhD

James D. Love, PhD
Vice President, Automation & Process Optimization, Novo Nordisk AS

Jay Sarkar, PhD

Jay Sarkar, PhD
Visiting Scholar, Stanford University

Sathya Venkataramani, PhD

Sathya Venkataramani, PhD
Associate Director, Biologics Discovery, Janssen Biotherapeutics

Jin Wang

Jin Wang
Director of Center for NextGen Therapeutics & Michael E. DeBakey, MD, Professor in Pharmacology, Baylor College of Medicine